A hospital-based study of survival in oral cancer patients of Tata Memorial Hospital, Mumbai

被引:1
作者
Lokhande, Monika [1 ,2 ]
Kannusamy, Sivaranjini [1 ,2 ]
Oak, Amey [1 ,2 ]
Cheulkar, Sandhya [1 ,2 ]
Chavan, Shalmali [1 ,2 ]
Mishra, Varsha [1 ,2 ]
Gode, Pragati [1 ,2 ]
Thakadiyil, Aijimol S. [1 ,2 ]
Mendhe, Saket [1 ,2 ]
Kadam, Supriya [1 ,2 ]
Balasubramaniam, Ganesh [1 ]
Chaturvedi, Pankaj [1 ]
Dikshit, Rajesh [1 ]
机构
[1] Homi Bhabha Natl Inst, Mumbai 400094, India
[2] Tata Mem Hosp, Ctr Canc Epidemiol, Hosp Canc Registries & Survival Studies, Div Canc Care, Mumbai 400094, India
关键词
oral cancer; sociodemographic factors; clinical factors; registry; survival; India; SQUAMOUS-CELL CARCINOMA; CAVITY;
D O I
10.3332/ecancer.2024.1669
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Oral cancer represents a significant global public health concern, with the death rate for lip and oral cavity malignancies experiencing a 1.40-fold increase worldwide in the past three decades. This retrospective study aimed to comprehensively understand overall survival (OS) and the influence of sociodemographic and clinical factors on patients diagnosed with oral cavity cancer. Materials and methods: The study focused on oral cancer patients enrolled in 2016 and treated at Tata Memorial Hospital, Mumbai, with a follow-up period extending to 5 years until 2021. Utilising the Kaplan-Meier technique and log-rank test, we examined OS and variations based on sociodemographic factors, while the Cox proportional hazard model allowed us to investigate the simultaneous impact of multiple factors on OS. Results: A total of 1,895 eligible participants were included. The overall 5-year survival rate was 65%. After adjusting for age, gender, education, primary site, tumour grade, TNM staging, treatment intention, status and modality, we found in our study oral cancer patients aged more than 60 years (HR = 1.37, 95% CI: 1.01-1.85, p-value 0.03), patients who had poorly differentiated carcinoma (HR = 2.44, 95% CI: 1.56-3.81, p-value < 0.001), belonged to stage IV as per TNM staging (HR = 2.44, 95% CI: 1.65-3.61, p-value < 0.001), patient who have received partial treatment (HR = 2.44, 95% CI: 1.65-3.61, p-value < 0.001) and only chemotherapy (HR = 3.56, 95% CI: 2.43-5.23, p-value < 0.001) found to have a higher hazard of dying while literate (HR = 0.73, 95% CI: 0.56-0.95, p-value 0.02) are protective. Limitations: The retrospective nature of the study posed constraints in exploring additional variable associations. Implication: Overall early detection, appropriate treatment, and regular follow-up are critical for improving the survival rate of patients with oral cavity cancer. Conclusion: This research proposes that improving the socioeconomic status and promoting proactive treatment-seeking behaviour is crucial for enhancing the survival of oral cancer patients. Cancer hospitals, in collaboration with the wider public healthcare system in India, which includes clinicians and policymakers, should consider these suggestions to enhance cancer treatment and control in low-middle-income countries.
引用
收藏
页数:12
相关论文
共 26 条
[1]   Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age [J].
Ansarin, Mohssen ;
De Berardinis, Rita ;
Corso, Federica ;
Giugliano, Gioacchino ;
Bruschini, Roberto ;
De Benedetto, Luigi ;
Zorzi, Stefano ;
Maffini, Fausto ;
Sovardi, Fabio ;
Pigni, Carolina ;
Scaglione, Donatella ;
Alterio, Daniela ;
Rocca, Maria Cossu ;
Chiocca, Susanna ;
Gandini, Sara ;
Tagliabue, Marta .
FRONTIERS IN ONCOLOGY, 2021, 11
[2]   Survival Analysis of Oral Squamous Cell Carcinoma Patients Attending Tertiary Care Centre of North India [J].
Bakshi, Jaimanti ;
Kaur, Navjot ;
Tiwana, Harsimran ;
Verma, Roshan K. ;
Panda, Naresh K. ;
Patro, Sourabha Kumar .
INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (01) :234-242
[3]   Squamous cell carcinoma of buccal mucosa: An analysis of prognostic factors [J].
Bobdey, Saurabh ;
Sathwara, Jignasa ;
Jain, Aanchal ;
Saoba, Sushma ;
Balasubramaniam, Ganesh .
SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) :49-54
[4]  
Borse Vivek, 2020, Sens Int, V1, P100046, DOI [10.1016/j.sintl.2020.100046, 10.1016/j.sintl.2020.100046]
[5]  
Cancer Treatment Centers of America Internet, 2022, Tongue Cancer: Symptoms, Causes, Treatment & Survival Rate
[6]   Survival Analysis of Oral Squamous Cell Carcinoma in a Subgroup of Young Patients [J].
Fan, Yi ;
Zheng, Lei ;
Mao, Ming-Hui ;
Huang, Ming-Wei ;
Liu, Shu-Ming ;
Zhang, Jie ;
Li, Sheng-Lin ;
Zheng, Lei ;
Zhang, Jian-Guo .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (20) :8887-8891
[7]   Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population [J].
Gleber-Netto, Frederico Omar ;
Yakob, Maha ;
Li, Feng ;
Feng, Ziding ;
Dai, Jianliang ;
Kao, Huang-Kai ;
Chang, Yu-Liang ;
Chang, Kai-Ping ;
Wong, David T. W. .
CLINICAL CANCER RESEARCH, 2016, 22 (13) :3340-3347
[8]  
Goswami S, 2022, Indian J Cancer
[9]  
Jitender S, 2016, J EXP THER ONCOL, V11, P303
[10]   CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma [J].
Kosunen, A. ;
Pirinen, R. ;
Ropponen, K. ;
Pukkila, M. ;
Kellokoski, J. ;
Virtaniemi, J. ;
Sironen, R. ;
Juhola, M. ;
Kumpulainen, E. ;
Johansson, R. ;
Nuutinen, J. ;
Kosma, V. -M. .
ORAL ONCOLOGY, 2007, 43 (01) :51-59